Atorvastatin Calcium Market Forecast: USD 369 Million by 2032 at Strong 8.1% CAGR — Increasing Statin Demand Fuels Growth
According to Intel Market Research, the global Atorvastatin Calcium market is set for solid growth from USD 216M (2024) to USD 369M by 2032 at an 8.1% CAGR, fueled by the rising burden of heart disease, wider adoption of generic statins, and expanding healthcare access across Asia-Pacific and Latin America.
The Atorvastatin Calcium market is set to grow from USD 216 million in 2024 to USD 369 million by 2032, registering an 8.1% CAGR. Rising cardiovascular disease cases, an aging global population, and expanding generic drug production—especially in India and China—are driving strong market growth.